MHA Today is provided as a service to members of the Missouri Hospital Association. Additional information is available online at MHAnet. In This Issue Congressional Query Probes EpiPen Misclassification MHA Provides Analysis Of Medicare Spending Per Beneficiary CMS Announces Person And Family Engagement Strategy
UPCOMING WEBINAR Recruitment and Retention Strategies: How to Attract and Keep the Best People Tuesday, Jan. 24, 2017 9 - 10:30 a.m.
Advocate state and federal health policy developments
Staff Contact: Daniel Landon Chairmen from the U.S. Senate Finance Committee and three committees and subcommittees of the U.S. House of Representatives have sent a letter to the Centers for Medicare & Medicaid Services regarding the alleged misclassification of the EpiPen drug device in the Medicaid drug rebate program. The EpiPen had been classified as a generic drug product, but CMS later asserted that it was misclassified and was a brand-name drug. The manufacturer of the EpiPen entered into a $465 million settlement agreement with federal agencies. A misclassification has significant financial implications for state Medicaid programs because of the higher drug rebates that drug manufacturers pay for brand-name drugs. The letter probes for details of CMS’ role in the matter. Back To Top
Staff Contact: Andrew Wheeler MHA has made available a report illustrating the average Medicare spending per beneficiary by hospital, with comparisons to average spending for Missouri and the nation. The information includes details about the spending up to three days before admission, during admission and up to 30 days post-discharge. The report is based on information released on the Centers for Medicare & Medicaid Services’ Hospital Compare website and uses data from Jan. 1, 2015, through Dec. 31, 2015. Policy and analytic studies, prepared for distribution by the Hospital Industry Data Institute, are made available for download to authorized users of HIDI Analytic Advantage.® Back To Top
Staff Contact: Andrew Wheeler The Centers for Medicare & Medicaid Services announced a new strategy that continues to focus on transforming the health care delivery system by providing better outcomes while spending dollars more wisely. The Person and Family Engagement Strategy is intended to encourage collaboration between patients and their families, and providers, while placing emphasis on the consideration of the health, values and goals of the individual. The PFE strategy includes the following four goals.
According to the American Medical Association, about 1 in 6 American adults reported taking at least one psychiatric drug, usually an antidepressant or an anti-anxiety medication, and most had been doing so for a year or more. Source: The JAMA Network